Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Machaon M. Bonafede

Cost of Tumor Necrosis Factor Blockers Per Patient With Rheumatoid Arthritis in a Multistate Medicaid Population

ClinicoEconomics and Outcomes Research

English

Retrospective Database Analysis of Clinical Outcomes and Costs for Treatment of Abnormal Uterine Bleeding Among Women Enrolled in US Medicaid Programs

ClinicoEconomics and Outcomes Research

English

Related publications

Costs of Tumor Necrosis Factor Blockers Per Treated Patient Using Real-World Drug Data in a Managed Care Population

Journal of Managed Care Pharmacy

2013

English

PMS15 Costs of Tumor Necrosis Factor Blockers Per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population

English

Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis

Journal of Managed Care Pharmacy

2014

English

Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis

English

Dermatomyositis Induced by Anti–Tumor Necrosis Factor in a Patient With Juvenile Idiopathic Arthritis

English

Tumor Necrosis Factor-Α Blockade Treatment Decreased CD154 (CD40-ligand) Expression in Rheumatoid Arthritis

PLoS ONE

Multidisciplinary

2017

English

PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy

English

Effect of Tumor Necrosis Factor Inhibitors on Interstitial Lung Disease in Rheumatoid Arthritis: Angel or Demon?

Drug Design, Development and Therapy

Drug Discovery

Pharmacology

Pharmaceutical Science

2019

English

Minimal Important Difference and Responsiveness to Change of the SF-36 in Patients With Psoriatic Arthritis Receiving Tumor Necrosis Factor- Blockers

Journal of Rheumatology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Machaon M. Bonafede

Cost of Tumor Necrosis Factor Blockers Per Patient With Rheumatoid Arthritis in a Multistate Medicaid Population

Retrospective Database Analysis of Clinical Outcomes and Costs for Treatment of Abnormal Uterine Bleeding Among Women Enrolled in US Medicaid Programs

Related publications

Costs of Tumor Necrosis Factor Blockers Per Treated Patient Using Real-World Drug Data in a Managed Care Population

PMS15 Costs of Tumor Necrosis Factor Blockers Per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population

Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis

Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis

Dermatomyositis Induced by Anti–Tumor Necrosis Factor in a Patient With Juvenile Idiopathic Arthritis

Tumor Necrosis Factor-Α Blockade Treatment Decreased CD154 (CD40-ligand) Expression in Rheumatoid Arthritis

PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy

Effect of Tumor Necrosis Factor Inhibitors on Interstitial Lung Disease in Rheumatoid Arthritis: Angel or Demon?

Minimal Important Difference and Responsiveness to Change of the SF-36 in Patients With Psoriatic Arthritis Receiving Tumor Necrosis Factor- Blockers